TL;DR
Hollows under the eyes are one of the most common reasons adults sit down in a cosmetic clinic, and today the usual fix is to fill them: a gel injected to plump the space. A Tennessee company wants to try something closer to repair. Lynch Regenerative Medicine says the FDA has cleared it to test an injection of a growth factor, a protein the body already uses to heal wounds, in up to 75 adults with under-eye hollowing. The pitch is that the shot would coax the body to rebuild its own tissue instead of parking a filler there. No one in the trial has been treated yet, there are no human results for this use, and the clearance comes from the company's own announcement. The ingredient itself is not new. Versions of it have been FDA-approved since 1997 for diabetic foot ulcers and gum repair, which gives this one a head start most experimental cosmetic treatments never get. If it works, "rejuvenation" around the eyes could start to mean regrowth rather than packing material. For the odds on a regrowth shot for under-eyes and a timeline of the trial steps ahead, subscribe.
Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.